A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

NCT00799136 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, AIDS Related
HIV Infections

Interventions

DRUG: R-EPOCH and cART

Sponsor

Ontario Clinical Oncology Group (OCOG)

Collaborators

[object Object]